Literature DB >> 12925967

Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study.

Silvia Franceschi1, Thangarajan Rajkumar, Salvatore Vaccarella, Vendhan Gajalakshmi, Ajit Sharmila, Peter J F Snijders, Nubia Muñoz, Chris J L M Meijer, Rolando Herrero.   

Abstract

To evaluate the role of human papillomavirus (HPV) and other risk factors in the aetiology of invasive cervical carcinoma (ICC), we conducted a hospital-based case-control study in Chennai, Southern India. A total of 205 ICC cases (including 12 adenocarcinomas) and 213 frequency age-matched control women were included. HPV DNA in cervical cells was evaluated by means of a polymerase chain-reaction assay. Odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were computed by means of unconditional multiple logistic regression models. HPV infection was detected in all but one ICC cases and in 27.7% of control women (OR = 498). Twenty-three different HPV types were found. HPV 16 was the most common type in either cases or controls, followed by HPV 18 and 33. The association of ICC with HPV 18 and HPV 16-associated types was somewhat stronger than the one with HPV 16. Multiple HPV infections did not show a higher OR for ICC than single infections. Other than HPV infection, high parity (OR for >4 vs. </=2 births = 7.3), a woman's report of her husband's extramarital sexual relationships (OR = 10.0) and early menopause (OR for <45 vs. >/=45 years = 4.2) were significantly associated with ICC, also after restricting the analysis to HPV-positive cases and controls. Poor hygienic conditions were associated with an increased risk of HPV infection among control women but not with ICC risk among HPV-positive women. A vaccine against HPV 16 and 18 may be effective in more than three-quarters of ICC in the study area. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12925967     DOI: 10.1002/ijc.11350

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  41 in total

1.  Human papillomavirus 45 genetic variation and cervical cancer risk worldwide.

Authors:  Alyce A Chen; Daniëlle A M Heideman; Debby Boon; Tarik Gheit; Peter J F Snijders; Massimo Tommasino; Silvia Franceschi; Gary M Clifford
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

2.  Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses.

Authors:  Mark L Bagarazzi; Jian Yan; Matthew P Morrow; David B Weiner; Niranjan Y Sardesai; Xuefei Shen; R Lamar Parker; Jessica C Lee; Mary Giffear; Panyupa Pankhong; Amir S Khan; Kate E Broderick; Christine Knott; Feng Lin; Jean D Boyer; Ruxandra Draghia-Akli; C Jo White; J Joseph Kim
Journal:  Sci Transl Med       Date:  2012-10-10       Impact factor: 17.956

3.  Detection of human papillomavirus in women attending Pap cervical screening camp at a peripheral hospital of North-Eastern India.

Authors:  Sibnarayan Datta; Manisha Agarwal; Soumya Chatterjee; Hemanta Kumar Gogoi; Vijay Veer; Lokendra Singh
Journal:  Med J Armed Forces India       Date:  2013-08-05

4.  Time since first sexual intercourse and the risk of cervical cancer.

Authors:  Martyn Plummer; Julian Peto; Silvia Franceschi
Journal:  Int J Cancer       Date:  2011-08-12       Impact factor: 7.396

5.  Cellular immunity induced by a novel HPV18 DNA vaccine encoding an E6/E7 fusion consensus protein in mice and rhesus macaques.

Authors:  Jian Yan; Kristina Harris; Amir S Khan; Ruxandra Draghia-Akli; Duane Sewell; David B Weiner
Journal:  Vaccine       Date:  2008-04-14       Impact factor: 3.641

6.  Cervical human papillomavirus infection in accra, ghana.

Authors:  Ab Domfeh; Ek Wiredu; Aa Adjei; Pfk Ayeh-Kumi; Tk Adiku; Y Tettey; Rk Gyasi; Hb Armah
Journal:  Ghana Med J       Date:  2008-06

7.  Human papillomavirus infection in women with and without cervical cancer in Karachi, Pakistan.

Authors:  S A Raza; S Franceschi; S Pallardy; F R Malik; B I Avan; A Zafar; S H Ali; S Pervez; S Serajuddaula; P J F Snijders; F J van Kemenade; C J L M Meijer; S Shershah; G M Clifford
Journal:  Br J Cancer       Date:  2010-04-20       Impact factor: 7.640

8.  Human papillomavirus-type distribution in women with and without cervical neoplasia in north India.

Authors:  Neerja Bhatla; Lalit Dar; A Rajkumar Patro; Pankaj Kumar; Sunil K Pati; Alka Kriplani; Arti Gulati; Shobha Broor; Venkateswaran K Iyer; Sandeep Mathur; Keerti V Shah; Patti E Gravitt
Journal:  Int J Gynecol Pathol       Date:  2008-07       Impact factor: 2.762

9.  Reproductive Tract infections and Premalignant Lesions of Cervix: Evidence from Women Presenting at the Cancer Detection Centre of the Indian Cancer Society, Delhi, 2000-2012.

Authors:  Subhojit Dey; Parika Pahwa; Arti Mishra; Jyotsna Govil; Preet K Dhillon
Journal:  J Obstet Gynaecol India       Date:  2016-03-11

10.  Differences in the risk of cervical cancer and human papillomavirus infection by education level.

Authors:  S Franceschi; M Plummer; G Clifford; S de Sanjose; X Bosch; R Herrero; N Muñoz; S Vaccarella
Journal:  Br J Cancer       Date:  2009-08-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.